Prognosis in Myelodysplastic Syndrome

October 1, 1999

Issue Date: October 1, 1999

Table of Contents

Prognosis in Myelodysplastic Syndrome
Year-Round Sunscreen and the Prevention of Skin Cancer
Mammography Screening Interval for Women Older Than 70 Years of Age
The MRC/EORTC Neoadjuvant Chemotherapy Trial for Advanced Bladder Cancer
An Inhibitor of p53 as a Normal Tissue Protector Against Cancer Therapy

Financial Disclosure: None of the authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients

Shop Now: Search Products

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements

Emergency
Hospital
Clinical
All Access
Help
Search
About Us
Newsletters
FreeCME

The trusted source for healthcare information and CONTINUING EDUCATION.

ACCOUNTS RECEIVABLE

AR@relias.com

MAILING ADDRESS

1010 Sync St., Suite 100

Morrisville, NC 27560-5468

USA

Do Not Sell My Personal Information
Privacy Policy
Terms Of Use
Help
Group Sales

For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com